Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,107,330
  • Shares Outstanding, K 51,007
  • Annual Sales, $ 967,580 K
  • Annual Income, $ 55,020 K
  • 60-Month Beta 0.85
  • Price/Sales 5.28
  • Price/Cash Flow 21.61
  • Price/Book 7.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.63
  • Number of Estimates 5
  • High Estimate 0.67
  • Low Estimate 0.60
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +6.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.61 +22.69%
on 04/22/19
102.39 -2.21%
on 05/16/19
+18.01 (+21.93%)
since 04/18/19
3-Month
80.24 +24.80%
on 04/18/19
102.39 -2.21%
on 05/16/19
+11.12 (+12.49%)
since 02/20/19
52-Week
80.24 +24.80%
on 04/18/19
117.56 -14.82%
on 10/01/18
+11.22 (+12.62%)
since 05/18/18

Most Recent Stories

More News
Here's Why You Should Retain Cooper Companies (COO) Stock

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.

COO : 289.48 (-1.11%)
HAE : 100.13 (+0.06%)
CSII : 39.27 (-0.68%)
QDEL : 55.63 (-0.78%)
3 Reasons Why Haemonetics (HAE) Is a Great Growth Stock

Haemonetics (HAE) could produce exceptional returns because of its solid growth attributes.

HAE : 100.13 (+0.06%)
Here's Why You Should Retain DaVita (DVA) in Your Portfolio

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, divestment of DMG segment might lower cash flows.

HAE : 100.13 (+0.06%)
DVA : 48.87 (-0.73%)
QDEL : 55.63 (-0.78%)
CSII : 39.27 (-0.68%)
Haemonetics Corp Rises 5.33% on Heavy Volume: Watch For Potential Pullback

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $97.15 to a high of $99.53. Yesterday, the shares gained 5.3%, which took the trading range above the 3-day high of...

HAE : 100.13 (+0.06%)
Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

HAE : 100.13 (+0.06%)
PKI : 84.06 (-2.19%)
CSII : 39.27 (-0.68%)
QDEL : 55.63 (-0.78%)
Haemonetics To Transfer Union, South Carolina, Manufacturing Facility To CSL Plasma Inc.

Haemonetics Corporation (NYSE: HAE) and CSL Plasma Inc. today announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories...

HAE : 100.13 (+0.06%)
CSLLY : 71.0400 (-0.08%)
Haemonetics Receives FDA Clearance For Expanded Use Of TEG® 6s Hemostasis Analyzer System In Adult Trauma Settings

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced today that it received 510(k)...

HAE : 100.13 (+0.06%)
Shares of Orasure Tech Rank the Highest in Terms of Relative Performance in the Health Care Supplies Industry (OSUR , CERS , HAE , XRAY , QDEL )

Here are the top 5 stocks in the Health Care Supplies industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

OSUR : 8.44 (-1.06%)
CERS : 5.39 (-1.46%)
HAE : 100.13 (+0.06%)
Haemonetics (HAE) Q4 Earnings Top Mark, Operating Margin Up

A steady momentum in new business wins and consistent geographical expansion drive Haemonetics' (HAE) top-line results

ABT : 75.77 (-0.26%)
SYK : 184.31 (+0.09%)
HAE : 100.13 (+0.06%)
CNMD : 80.02 (-0.37%)
Haemonetics (HAE) Surpasses Q4 Earnings Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of 10.91% and -0.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

HAE : 100.13 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade HAE with:

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

2nd Resistance Point 102.63
1st Resistance Point 101.38
Last Price 100.13
1st Support Level 98.60
2nd Support Level 97.07

See More

52-Week High 117.56
Fibonacci 61.8% 103.30
Last Price 100.13
Fibonacci 50% 98.90
Fibonacci 38.2% 94.49
52-Week Low 80.24

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar